RP 66784
Alternative Names: RP 66266Latest Information Update: 23 Sep 1997
At a glance
- Originator Aventis
- Class Antihypertensives; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Hypertension
Most Recent Events
- 23 Sep 1997 No-Development-Reported for Angina pectoris in France (Unknown route)
- 23 Sep 1997 No-Development-Reported for Hypertension in France (Unknown route)
- 24 Oct 1994 Preclinical development for Angina pectoris in France (Unknown route)